Le Lézard
Classified in: Health, Business
Subject: FDA

Water Street's Partnership with Leading Medical Products Company Leads to FDA Approval of the First and Only Ready-to-Use Insulin for IV Infusion


CHICAGO, July 22, 2019 /PRNewswire/ -- Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, announced today that its development partnership with a leading medical products company has resulted in the U.S. Food and Drug Administration (FDA) approval of Insulin Human in 0.9% Sodium Chloride Injection (Insulin Human). It is the first and only ready-to-use insulin for IV infusion.

Water Street Healthcare Logo (PRNewsfoto/Water Street Healthcare Partners)

The new presentation of Insulin Human features an extended shelf life of 30 days at room temperature (77 degrees Fahrenheit /25 degrees Celsius) or 24 months if refrigerated (36 ? 46 degrees Fahrenheit/2-8 degrees Celsius) in the original carton to protect from light. The product is provided in a standardized concentration of 100 units/100 mL in a flexible plastic container.

The approval of Insulin Human marks the eighth drug product successfully developed by Water Street's company, Celerity Pharmaceuticals, LLC. Celerity funded, developed, and led the approval process of Insulin Human. After gaining FDA approval, Celerity transferred ownership of the product to its medical products company partner.

"We're honored to be part of successfully developing this innovative presentation of insulin to advance our partner's goal of introducing medicines in new presentations that help promote clinician efficiency and advance patient care," said Dan Robins, Ph.D., president, Celerity. 

About Water Street
Water Street is a strategic investor focused exclusively on health care. The firm has a strong record of building market-leading companies across key growth sectors in health care. It has worked with some of the world's leading health care companies on its investments including Humana, Johnson & Johnson, Medtronic, and Walgreen Co. Water Street's team is comprised of industry executives and investment professionals with decades of experience investing in and operating global health care businesses. The firm is headquartered in Chicago. For more information about Water Street, visit waterstreet.com.

SOURCE Water Street Healthcare Partners


These press releases may also interest you

at 19:05
Celltrion Healthcare today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for CT-P13 SC for marketing authorisation in the European Union (EU) in people...

at 19:01
At the time of the year when workers' thoughts traditionally turn to the long stretch between the end of the holidays and Christmas, a survey* conducted by Achievers has revealed that over half of UK employees were dreading returning to work after...

at 16:10
Red Spot Interactive (RSI), a return on investment (ROI) driven patient acquisition and retention software platform supporting more than 30 medical practice management systems, has partnered with Symplast, the No. 1 mobile EHR/practice management...

at 15:30
On Monday, September 23rd, a CMA delegation led by President Dr. Sandy Buchman will attend the United Nations (UN) meeting on Universal Health Care in New York City. The meeting will bring heads of state, political and health leaders, policy-makers...

at 14:00
Knieling's work on a light- and sound-based imaging technique has been shown to have potential benefits for patients suffering from Crohn's Disease and Duchenne Muscular Dystrophy. By detection of local changes in hemoglobin and collagen...

at 11:05
Pathologists are increasingly optimistic about the potential of the human microbiome to help guide diagnosis and monitoring of chronic diseases. The microbiome includes a vast array of bacteria, viruses and fungi living throughout the body that are...



News published on 22 july 2019 at 09:45 and distributed by: